Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gobbi Novag is a prominent Argentine pharmaceutical company specializing in the development, production, and commercialization of high-complexity medications. The firm focuses on critical therapeutic areas such as oncology, hematology, nephrology, and rheumatology, providing essential treatments for life-threatening and chronic conditions. Headquartered in Buenos Aires, Gobbi Novag operates sophisticated manufacturing plants that adhere to international quality standards, ensuring the delivery of safe and effective therapies. The company plays a vital role in the Latin American healthcare landscape by offering a mix of proprietary products and licensed innovative drugs through strategic global partnerships. Led by Claudio Gobbi, the organization is committed to improving patient outcomes through specialized pharmaceutical care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Claudio Gobbi.